Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

LaSara Medical Group vs Transcarent

LaSara Medical Group
Graded #456

Lower grade

vs+0.7000000000000028
Transcarent
Graded #445

Higher grade

The verdict

Transcarent takes it — 55.2/100 to 54.5/100, but only just.

Transcarent grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Transcarent delivers a Weight Health experience for self-insured employers and health plans, combining behavioral coaching, GLP-1 medication management when covered and appropriate, nutrition guidance and… LaSara Medical Group is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueTranscarent +12
33
45
Dose & formulationLaSara Medical Group +24
64
40
Clinical oversightTranscarent +6
69
75
Labs & monitoringTranscarent +8
53
61
FulfillmentLaSara Medical Group +4
66
62
Contract termsTranscarent +8
47
55
LaSara Medical Group · left barTranscarent · right bar

The numbers

MetricLaSara Medical GroupTranscarent
WeighScore54.5/10055.2/100
GradeCC
Scorecard rank#456#445
Semaglutide$289/mo (compounded)Not disclosed
Tirzepatide$399/mo (bundle, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
LaSara Medical Group

Graded #456 · C

Strengths

  • Multi-modality clinic — compounded GLP-1s alongside TRT, peptides, B12, NAD+, sermorelin, and enclomiphene
  • National telehealth plus an in-person option in Southern California — uncommon hybrid model
  • Free initial consultation
  • Active promotional pricing (30% off sitewide at the time of review)
  • GLP-1 pricing now published on product pages: compounded semaglutide from $233/mo, tirzepatide from $325/mo on annual bundles

Where it loses points

  • Legal entity name and state of incorporation not disclosed
  • Compounding pharmacy partner not named
  • LegitScript certification status not confirmed
  • Per-state availability not listed despite the national-telehealth claim
  • Lab work and ongoing monitoring inclusion not clearly disclosed for the multi-modality menu
Transcarent

Graded #445 · C

Strengths

  • Comprehensive Weight Health pathway from lifestyle to GLP-1s to surgery
  • Care team of doctors, nurses and pharmacists supports medication use
  • Uses direct pharma contracts and a transparent PBM to cut costs
  • Integrates bariatric surgery navigation alongside medication
  • Built on 15 years of Surgery Center of Excellence experience

Where it loses points

  • Distributed only via employers and health plans, no direct cash-pay
  • GLP-1 access depends on whether the plan covers the medication
  • No public individual monthly pricing
  • Not available to consumers without an eligible employer or plan

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard